Agios Pharmaceuticals, Inc. (AGIO) is a publicly traded Healthcare sector company. As of August 24, 2026, AGIO trades at $33.09 with a market cap of $1.98B and a P/E ratio of -4.73. AGIO moved -1.53% today. Year to date, AGIO is +21.57%; over the trailing twelve months it is -13.38%. Its 52-week range spans $22.24 to $46.00. Analyst consensus is buy with an average price target of $41.33. Rallies surfaces AGIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for AGIO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $33.09 |
| Market Cap | $1.98B |
| P/E Ratio | -4.73 |
| EPS | $-7.01 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.00 |
| 52-Week Low | $22.24 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $98.34M |
| Net Income | $-411.29M |
| Gross Margin | 91.99% |
9 analysts cover AGIO: 0 strong buy, 6 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $41.33.